Your browser doesn't support javascript.
loading
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors.
Lebedev, Timofey D; Khabusheva, Elmira R; Mareeva, Sofia R; Ivanenko, Karina A; Morozov, Alexey V; Spirin, Pavel V; Rubtsov, Petr M; Snezhkina, Anastasiya V; Kudryavtseva, Anna V; Sorokin, Maxim I; Buzdin, Anton A; Prassolov, Vladimir S.
Afiliação
  • Lebedev TD; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Electronic
  • Khabusheva ER; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Mareeva SR; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Moscow Region, Russia.
  • Ivanenko KA; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Morozov AV; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Spirin PV; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Rubtsov PM; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Snezhkina AV; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Kudryavtseva AV; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
  • Sorokin MI; Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia; Group for Genomic Regulation of Cell Signaling Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia; Department of Bioinformatics and Molecular Networks, OmicsWay Corp, Wal
  • Buzdin AA; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Moscow Region, Russia; Institute of Personalized Oncology, Sechenov First Moscow State Medical University, Moscow, Russia; Group for Genomic Regulation of Cell Signaling Systems, Shemyakin-Ovchinnikov Institute o
  • Prassolov VS; Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
J Biol Chem ; 298(8): 102226, 2022 08.
Article em En | MEDLINE | ID: mdl-35787369
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article